L&C Bio (290650.KQ) Earnings Analysis
L&C Bio (290650.KQ) next reports earnings on 2026-08-19, consensus EPS 140.94 KRW. Trailing P/E -11.00.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 290650.KQ next report earnings?
| Next earnings date | 2026-08-19 |
|---|---|
| Consensus EPS estimate | 140.94 KRW |
| Revenue estimate | 39.70B |
290650.KQ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | 104.64 KRW | n/a | n/a | n/a |
| 2026-02-27 | -2,945.42 KRW | n/a | n/a | n/a |
| 2025-11-14 | -2,289 KRW | n/a | n/a | n/a |
| 2025-08-14 | -605.33 KRW | n/a | n/a | n/a |
| 2025-05-15 | -18.85 KRW | n/a | n/a | n/a |
| 2025-02-24 | 6,431.2 KRW | n/a | n/a | n/a |
| 2024-11-14 | -228 KRW | n/a | n/a | n/a |
| 2024-08-14 | 46.95 KRW | n/a | n/a | n/a |
290650.KQ valuation and analyst view
| Trailing P/E | -11.00 |
|---|---|
| Trailing EPS | -5,193.66954 KRW |
| Price / book | 8.09 |
| Dividend yield | 0.08% |
| Market cap | 1501.50B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is L&C Bio (290650.KQ)'s next earnings date?
L&C Bio is next scheduled to report on 2026-08-19, with a consensus EPS estimate of 140.94 KRW and revenue estimate of 39.70B.
Did 290650.KQ beat earnings last quarter?
Consensus estimate data was not available for 290650.KQ's 2026-05-11 report.
What is 290650.KQ's current P/E ratio and EPS?
290650.KQ trades at a trailing P/E of -11.00 on trailing EPS of -5193.669536143884 KRW.
What do analysts rate 290650.KQ?
290650.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.